Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
about
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@en
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@nl
type
label
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@en
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@nl
prefLabel
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@en
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
@nl
P2093
P2860
P356
P1476
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype
@en
P2093
Ales Belic
Dávid Sirok
Edit Háfra
Gábor Csukly
Katalin Monostory
Katalin Tóth
Ádám Menus
P2860
P356
10.1093/IJNP/PYW083
P577
2016-12-30T00:00:00Z